Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
IMMUNE cell gene therapy startup Gracell Biotechnologies has raised US$85 million through a Series B round led by Singapore government investment firm Temasek Holdings.
Also taking part in the financing round were Lilly Asia Ventures, Kington Capital, King Star Capital...